Aspergillosis News and Research

RSS

Incidence and risk factors of an invasive fungal lung infection among COVID-19 patients

Study reveals 0.4%-2.7% incidence of COVID-19-associated pulmonary aspergillosis in severe patients, highlighting significant mortality risks and risk factors.

24 Sep 2024

Researchers analyze incidence of COVID-19-associated pulmonary aspergillosis in Japan

As society learns to live with COVID-19, research on the disease and its complications remains important.

20 Sep 2024

Promising new strategy to combat fungal infections

A group of Brazilian researchers has found a potential target for novel therapeutic strategies to combat fungal infections – more specifically, those caused by Aspergillus fumigatus. An article reporting the discovery is published in the journal Communications Biology.

5 Sep 2024

Immunoregulatory nanomedicines for the prevention and treatment of respiratory diseases

Study explores immunoregulatory nanomedicines for respiratory infections, highlighting their potential in enhancing treatment outcomes and vaccine efficacy.

7 Dec 2023

Fighting invisible foes: How cryptic fungal pathogens threaten human health and food security

The research paper in PLOS Pathogens delves into the challenges of diagnosing and treating cryptic fungal pathogens, which are difficult to distinguish from common fungi but equally dangerous. The study calls for more accurate diagnostic methods and a better understanding of how these fungi interact with the human immune system and microbiome for effective treatment and prevention.

25 Oct 2023

Color of the phlegm can indicate degree of lung inflammation in patients with bronchiectasis

The color of the phlegm from patients with the lung disease bronchiectasis can indicate the degree of inflammation in their lungs and predict their future outcomes, according to new research presented at the European Respiratory Society International Congress in Milan, Italy.

11 Sep 2023

Understanding the mechanisms behind rising antifungal drug resistance

In a recent study, researchers addressed the issue of the rise of antifungal drugs-resistant infections and the advent of multidrug-resistant fungal pathogens.

19 Jul 2023

New drug shows synergistic effect with antifungals in killing drug-resistant fungi

A study conducted at the University of São Paulo (USP) in Brazil shows that brilacidin, a new drug tested for treatment of diseases ranging from bacterial skin infections to COVID-19, can kill drug-resistant strains of fungi when combined with two classes of antifungals available on the market.

10 Jul 2023

How did the COVID-19 pandemic impact the fungal infection hospitalization rates?

Researchers examined hospitalizations for fungal infections during the coronavirus disease 2019.

9 Jun 2023

Analyzing impact of phospholipase D on the host immune response to A. fumigatus infection

Announcing a new article publication for Zoonoses journal. Aspergillus fumigatus infection in the lungs is accompanied by the recruitment of innate immune cells, phagocytosis, and the release of inflammatory factors.

11 May 2023

How antiviral host responses create a lung environment susceptible to bacterial and fungal infections

A recent study discussed coinfections in the lungs and how viral infections create a favorable environment for bacteria and fungi.

8 May 2023

New insights into deadly fungal invasion in people with compromised immune systems

Fungi such as Aspergillus are so common in our surroundings that we breathe in hundreds to thousands of spores every day.

12 Jan 2023

Shared genetic effects between the autoimmune disease systemic lupus erythematosus and the clinical consequences of COVID-19

Researchers identified a genetic association signal, via genome-wide association studies, between severe COVID-19 with systemic lupus erythematosus, an autoimmune disease.

7 Nov 2022

Aspergillosis News and Research

Incidence and risk factors of an invasive fungal lung infection among COVID-19 patients

Researchers analyze incidence of COVID-19-associated pulmonary aspergillosis in Japan

Promising new strategy to combat fungal infections

Immunoregulatory nanomedicines for the prevention and treatment of respiratory diseases

Fighting invisible foes: How cryptic fungal pathogens threaten human health and food security

Color of the phlegm can indicate degree of lung inflammation in patients with bronchiectasis

Understanding the mechanisms behind rising antifungal drug resistance

New drug shows synergistic effect with antifungals in killing drug-resistant fungi

How did the COVID-19 pandemic impact the fungal infection hospitalization rates?

Analyzing impact of phospholipase D on the host immune response to A. fumigatus infection

How antiviral host responses create a lung environment susceptible to bacterial and fungal infections

New insights into deadly fungal invasion in people with compromised immune systems

Shared genetic effects between the autoimmune disease systemic lupus erythematosus and the clinical consequences of COVID-19

An unprecedented list of health-threatening fungi released by the WHO

Study presents rare cases of COVID-19-associated pulmonary aspergillosis

Exploring remdesivir resistance in COVID-19-infected transplant recipients

Novel antifungal medications urgently needed to control COVID-19-associated fungal infections

High prevalence of fungal secondary infections among COVID-19 patients

Scientists explore COVID-19-associated pulmonary aspergillosis

Drug-resistant mold found to be spreading and infecting susceptible people's lungs

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News